drugset / Trial / NCT02781259

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

NCT02781259

Phase 4 Unknown 150 enrolled Samsung Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

In this study, navigation of lymphatic passage after sentinel lymph node with indocyanine green was performed during axillary lymph node dissection in breast surgery . By comparing the concordance between the passage of indocyanine green and actual lymph node metastasis, selective lymph node dissection can be developed.

Timeline

Start
2016-05
Primary completion
2017-02
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 20 ug/ml
Subject Indocyanine Green Diagnostic / imaging agent 10 ml

Indications